Henry C Mwandumba Selected Research

Therapeutics

1/2023	How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
12/2022	High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi.
11/2021	Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
1/2021	New management approaches to tuberculosis in people living with HIV.
1/2020	A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
1/2019	Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi.
1/2019	Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
11/2018	AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
10/2017	HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy.
7/2015	Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry C Mwandumba Research Topics

Disease

7	Cryptococcal Meningitis 01/2023 - 11/2018
7	Pulmonary Tuberculosis 10/2022 - 07/2007
7	Tuberculosis (Tuberculoses) 11/2021 - 07/2015
5	COVID-19 01/2022 - 08/2020
3	Infections 01/2022 - 04/2004
2	Meningoencephalitis 01/2023 - 12/2022
2	Hypertension (High Blood Pressure) 12/2022 - 09/2020
1	Diabetes Mellitus 12/2022
1	Overweight 12/2022
1	Obesity 12/2022
1	Lymphadenopathy 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2020
1	Carotid Artery Diseases 09/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Noncommunicable Diseases 01/2019
1	HIV Infections (HIV Infection) 10/2017
1	Central Nervous System Vasculitis 01/2017
1	Stroke (Strokes) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2016
1	Lung Diseases (Lung Disease) 01/2008

Drug/Important Bio-Agent (IBA)

5	liposomal amphotericin B FDA Link 01/2023 - 11/2018
3	Flucytosine (Ancobon)FDA Link 01/2023 - 01/2022
3	deoxycholate drug combination amphotericin BIBA 01/2023 - 01/2022
3	Rifampin (Rifampicin)FDA LinkGeneric 10/2022 - 01/2017
3	CytokinesIBA 11/2021 - 01/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 07/2015
2	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 01/2022
2	Isoniazid (Ftivazide)FDA LinkGeneric 10/2022 - 11/2021
2	AntibodiesIBA 01/2022 - 08/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 11/2021
2	VaccinesIBA 12/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 07/2020
2	Superoxides (Superoxide)IBA 01/2017 - 10/2013
1	LipidsIBA 12/2022
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 12/2022
1	oxidized low density lipoproteinIBA 12/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	Antitubercular AgentsIBA 11/2021
1	Ethambutol (Myambutol)FDA LinkGeneric 11/2021
1	Pyrazinamide FDA LinkGeneric 11/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	beta-LactamsIBA 11/2021
1	ChemokinesIBA 11/2021
1	lipoarabinomannan (LAM)IBA 12/2020
1	ThrombomodulinIBA 09/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	RNA (Ribonucleic Acid)IBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2016
1	LipopolysaccharidesIBA 07/2007
1	AerosolsIBA 04/2004

Therapy/Procedure

10	Therapeutics 01/2023 - 07/2015
3	Art Therapy 01/2022 - 10/2014
1	Personal Protective Equipment 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2017